Pfizer Inc. today announced that a wholly-owned Polish subsidiary of Pfizer has acquired the rights to Polocard, a low-dose aspirin (acidum acetylsalicylicum), and the leading over-the-counter brand for heart attack prevention in Poland, from ZF Polpharma SA.
Pfizer's Polish subsidiary acquires rights to Polocard from ZF Polpharma SA
Monday, December 2, 2013
Pfizer's Polish subsidiary acquires rights to Polocard from ZF Polpharma SA
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment